Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Disease-modifying treatments for multiple sclerosis - a review of approved medications.
S1P1 deletion in oligodendroglial lineage cells: Effect on differentiation and myelination.
Increased frequency and severity of restless legs syndrome in patients with neuromyelitis optica spectrum disorder.
Ultrasound of inherited vs. acquired demyelinating polyneuropathies.
Tyrosine Kinase Inhibitor as a new Therapy for Ischemic Stroke and other Neurologic Diseases: is there any Hope for a Better Outcome?
Interleukin 6 Receptor Blockade in Patients With Neuromyelitis Optica Nonresponsive to Anti-CD20 Therapy.
Retinal nerve fiber layer thickness and neurologic disability in relapsing-remitting multiple sclerosis.
Feasibility study design and methods for Project GEMS: Guidelines for Exercise in Multiple Sclerosis.
Longitudinal extensive transverse myelitis with cervical epidural haematoma following dengue virus infection.
Characteristics of demyelinating Charcot-Marie-Tooth disease with concurrent diabetes mellitus.
Store-operated Calcium Entry into B Cells Regulates Autoimmune Inflammation.
Sativex(®) (tetrahydrocannabinol + cannabidiol), an endocannabinoid system modulator: basic features and main clinical data.
MicroRNA: Key regulators of oligodendrocyte development and pathobiology.
A gene expression study denies the ability of 25 candidate biomarkers to predict the interferon-beta treatment response in multiple sclerosis patients.
Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.
Molecular mechanisms linking neuroinflammation and neurodegeneration in MS.
Hypomyelination following deletion of Tsc2 in oligodendrocyte precursors.
Human polyoma JC virus minor capsid proteins, VP2 and VP3, enhance large T antigen binding to the origin of viral DNA replication: Evidence for their involvement in regulation of the viral DNA replication.
Correction: Predicting Relapsing-Remitting Dynamics in Multiple Sclerosis Using Discrete Distribution Models: A Population Approach.
Teriflunomide for the treatment of relapsing-remitting multiple sclerosis: patient preference and adherence.
Editorial Comments: Is multiple sclerosis a neurodegenerative or inflammatory disease?
Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method.
Body Esteem Among Women with Multiple Sclerosis and its Relationship with Demographic, Clinical and Socio-Psychological Factors.
Assessment of the effect of cigarette smoking on regional brain volumes and lesion load in patients with clinically isolated syndrome.
Chronic Inflammatory Pure Sensory Polyradiculoneuropathy: A Rare CIDP Variant With Unusual Electrophysiology.
Pages
« first
‹ previous
…
655
656
657
658
659
660
661
662
663
…
next ›
last »